Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACE-Neuro: A Tailored Exercise Oncology Program for Neuro-Oncology Patients

NCT04831190 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04831190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04831190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACE-Neuro: A Tailored Exercise Oncology Program for Neuro-Oncology Patients
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Unknown status
Start date
April 15, 2021
Completion date
April 15, 2024
Enrollment
70 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, primary, cancer